Literature DB >> 7529047

Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours.

M A Nagai1, L Yamamoto, S Salaorni, M M Pacheco, M M Brentani, E M Barbosa, R R Brentani, S Mazoyer, S A Smith, B A Ponder.   

Abstract

Linkage studies have indicated that a gene on chromosome arm 17q, designated BRCA1, confers susceptibility to familial breast and ovarian cancer. To investigate the possible involvement of the BRCA1 gene in sporadic breast cancer we have analysed loss of heterozygosity (LOH) in a panel of 100 sporadic primary breast tumours using 10 PCR-based polymorphic markers from 17q12-21. Allele losses were detected in 40 of 100 tumours informative for at least one of the markers analysed. Of these 40 deleted tumours, 27 showed partial or interstitial loss on 17q. The pattern of LOH in the tumours with partial or interstitial LOH revealed three putative distinct deleted regions on 17q12-21. The first lies on the proximal long arm between D17S250 and THRA1; the second one lies between D17S776 and D17S579, the region containing the BRCA1 gene; and the third is telomeric to D17S733. The most frequently deleted region overlaps with the minimal region containing the BRCA1 gene, suggesting that this gene might also be associated with the development or progression of a proportion of sporadic breast tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529047     DOI: 10.1002/gcc.2870110109

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Lessons from a decade of integrating cancer copy number alterations with gene expression profiles.

Authors:  Norman Huang; Parantu K Shah; Cheng Li
Journal:  Brief Bioinform       Date:  2011-09-23       Impact factor: 11.622

Review 3.  Molecular genetics of familial breast-ovarian cancer.

Authors:  E J van Rensburg; B A Ponder
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

4.  A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.

Authors:  A Arason; A Jonasdottir; R B Barkardottir; J T Bergthorsson; M D Teare; D F Easton; V Egilsson
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

5.  BRCA1-Dependent Translational Regulation in Breast Cancer Cells.

Authors:  Estelle Dacheux; Anne Vincent; Nicolas Nazaret; Christophe Combet; Anne Wierinckx; Sylvie Mazoyer; Jean-Jacques Diaz; Joël Lachuer; Nicole Dalla Venezia
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Authors:  A Jakubowska; D Rozkrut; A Antoniou; U Hamann; R J Scott; L McGuffog; S Healy; O M Sinilnikova; G Rennert; F Lejbkowicz; A Flugelman; I L Andrulis; G Glendon; H Ozcelik; M Thomassen; M Paligo; P Aretini; J Kantala; B Aroer; A von Wachenfeldt; A Liljegren; N Loman; K Herbst; U Kristoffersson; R Rosenquist; P Karlsson; M Stenmark-Askmalm; B Melin; K L Nathanson; S M Domchek; T Byrski; T Huzarski; J Gronwald; J Menkiszak; C Cybulski; P Serrano; A Osorio; T R Cajal; M Tsitlaidou; J Benítez; M Gilbert; M Rookus; C M Aalfs; I Kluijt; J L Boessenkool-Pape; H E J Meijers-Heijboer; J C Oosterwijk; C J van Asperen; M J Blok; M R Nelen; A M W van den Ouweland; C Seynaeve; R B van der Luijt; P Devilee; D F Easton; S Peock; D Frost; R Platte; S D Ellis; E Fineberg; D G Evans; F Lalloo; R Eeles; C Jacobs; J Adlard; R Davidson; D Eccles; T Cole; J Cook; A Godwin; B Bove; D Stoppa-Lyonnet; V Caux-Moncoutier; M Belotti; C Tirapo; S Mazoyer; L Barjhoux; N Boutry-Kryza; P Pujol; I Coupier; J-P Peyrat; P Vennin; D Muller; J-P Fricker; L Venat-Bouvet; O Th Johannsson; C Isaacs; R Schmutzler; B Wappenschmidt; A Meindl; N Arnold; R Varon-Mateeva; D Niederacher; C Sutter; H Deissler; S Preisler-Adams; J Simard; P Soucy; F Durocher; G Chenevix-Trench; J Beesley; X Chen; T Rebbeck; F Couch; X Wang; N Lindor; Z Fredericksen; V S Pankratz; P Peterlongo; B Bonanni; S Fortuzzi; B Peissel; C Szabo; P L Mai; J T Loud; J Lubinski
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

7.  Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

Authors:  Amandine I Garcia; Monique Buisson; Pascale Bertrand; Ruth Rimokh; Etienne Rouleau; Bernard S Lopez; Rosette Lidereau; Ivan Mikaélian; Sylvie Mazoyer
Journal:  EMBO Mol Med       Date:  2011-04-05       Impact factor: 12.137

8.  MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

9.  Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.

Authors:  H E Feilotter; V Coulon; J L McVeigh; A H Boag; F Dorion-Bonnet; B Duboué; W C Latham; C Eng; L M Mulligan; M Longy
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.

Authors:  S Staff; J J Isola; O Johannsson; A Borg; M M Tanner
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.